Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 19, 2009
Is it too early to recommend patent foramen ovale closure for all patients who suffer from migraine? A single-centre studyMassimo Chessa, Chiara Colombo, Gianfranco Butera, et al.
Frontiers in Neurology|April 9, 2020
Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1Marco Alì, Caterina Beatrice Monti, Luca Melazzini, et al.
Frontiers in Endocrinology|November 30, 2017
Circulating Irisin Is Reduced in Male Patients with Type 1 and Type 2 Myotonic DystrophiesElena Dozio, Elena Passeri, Rosanna Cardani, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 8, 2023
Myotonic dystrophy type 1 in the COVID-19 eraJelena Ilic Zivojinovic, Katarina Djurdjevic, Ivo Bozovic, et al.
Scientific Reports|July 25, 2018
SCN4A as modifier gene in patients with myotonic dystrophy type 2Anna Binda, Laura V Renna, Francesca Bosè, et al.
Frontiers in Neurology|October 16, 2019
<i>TNNT2</i> Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2Francesca Bosè, Laura Valentina Renna, Barbara Fossati, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 19, 2022
Clinical score for early diagnosis of myotonic dystrophy type 2Vukan Ivanovic, Stojan Peric, Jovan Pesovic, et al.
Genetic Testing and Molecular Biomarkers|October 28, 2015
Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2Rea Valaperta, Fortunata Lombardi, Rosanna Cardani, et al.
Neuroimage. Clinical|January 31, 2021
Lesion distribution and substrate of white matter damage in myotonic dystrophy type 1: Comparison with multiple sclerosisSara Leddy, Laura Serra, Davide Esposito, et al.
Pageof 11